| COVID-19 |
1 |
1 |
| Heart |
0 |
0.99 |
| Cardiovascular Risk Management |
0 |
0.47 |
| Triglycerides |
0 |
0.42 |
| Lipids Management |
0 |
0.34 |
| Atrial Fibrillation |
0 |
0.33 |
| Minerals |
0 |
0.28 |
| Respiratory Failure |
0 |
0.28 |
| Severe Acute Respiratory Syndrome |
0 |
0.28 |
| Steroids |
0 |
0.28 |
| Thromboembolism |
0 |
0.2 |
| Acute Respiratory Distress Syndrome |
0 |
0.17 |
| Diarrhea |
0 |
0.17 |
| Acute Coronary Syndrome |
0 |
0.14 |
| Adverse Effects |
0 |
0.14 |
| Anti-inflammatory Agents |
0 |
0.98 |
| Antithrombotics |
0 |
0.14 |
| Brachial |
0 |
0.14 |
| C-Reactive Protein (CRP) |
0 |
0.14 |
| Cytokines |
0 |
0.14 |
| Europe |
0 |
0.14 |
| Fatty Acids |
0 |
0.14 |
| Fish Oil |
0 |
0.14 |
| Infarction |
0 |
0.14 |
| Intubation |
0 |
0.14 |
| Cerebrovascular Accident |
0 |
0.09 |
| Gout |
0 |
0.09 |
| Influenza |
0 |
0.09 |
| Mechanical Ventilation |
0 |
0.09 |
| Myocardial Infarction (MI) |
0 |
0.09 |
| Patient Safety |
0 |
0.09 |